Total Funding
34
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.
Peter Daddona: Exec VP, CSOPast Role: University of Michigan, Associate Professor of Biological Chemistry and Internal Medicine
Chris Kruegar: Chief Business OfficerPast Role: Xencor, Senior Executive Roles
About the Company
Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization.
It was founded in 2006 and headquartered in Fremont, California.
